Viewing StudyNCT00344149



Ignite Creation Date: 2024-05-05 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00344149
Status: COMPLETED
Last Update Posted: 2014-03-26
First Post: 2006-06-22

Brief Title: Rituximab as Second Line Treatment for ITP
Sponsor: Ostfold Hospital Trust
Organization: Ostfold Hospital Trust

Conditions & Keywords Data

Conditions:
Name
Immune Thrombocytopenia ITP
Keywords:
Name View
treatment of Idiopathic Thrombocytopenic Purpura View
Idiopathic Thrombocytopenic Purpura View
Rituximab View
Splenectomy View
Response View
Treatment View